Dobrava-Belgrade virus: Phylogeny, epidemiology, disease

Antiviral Research

Volumn 95, Issue 2, 2012, Pages 104-117

  Papa, Anna ^a  

^a ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

Author keywords

Bunyavirus; Dobrava Belgrade virus; Hantavirus; Hemorrhagic fever with renal syndrome; Zoonosis

Indexed keywords

1 BETA DEXTRO RIBOFURANOSYL 3 ETHYL[1,2,4]TRIAZOLE; ANTIVIRUS AGENT; DOBRAVA BELGRADE VIRUS VACCINE; HISTAMINE H2 RECEPTOR ANTAGONIST; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HTNV; PUUMALA VIRUS DOBRAVA BELGRADE VIRUS VACCINE; RIBAVIRIN; UNCLASSIFIED DRUG; VASOACTIVE AGENT; VIRUS VACCINE;

APODEMUS FLAVICOLLIS; CLINICAL FEATURE; DOBRAVA BELGRADE VIRUS; ELECTROLYTE INTAKE; ENDEMIC DISEASE; EXPERIMENTAL MODEL; GASTROINTESTINAL HEMORRHAGE; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HANTAVIRUS; HANTAVIRUS INFECTION; HEMOLYTIC ANEMIA; HEMORRHAGIC FEVER; HUMAN; HYDRATION; LABORATORY TEST; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; OXYGENATION; PHYLOGENY; PRIORITY JOURNAL; REPRODUCTIVE TOXICITY; REVIEW; RODENT; SHOCK; SIDE EFFECT; TERATOGENESIS; UNINDEXED SEQUENCE; VIRION; VIRUS GENOME; VIRUS PATHOGENESIS;

ANIMALS; EUROPE; GENETIC VARIATION; HANTAVIRUS; HANTAVIRUS INFECTIONS; HUMANS; MURINAE; PHYLOGENY; RNA, VIRAL; TOPOGRAPHY, MEDICAL;

APODEMUS; APODEMUS AGRARIUS; APODEMUS FLAVICOLLIS; APODEMUS PONTICUS; DOBRAVA-BELGRADE VIRUS; HANTAVIRUS; ORTHOBUNYAVIRUS; RODENTIA;

EID: 84863818199     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2012.05.011     Document Type: Review

References (171)

1. Aitichou M., Saleh S.S., McElroy A.K., Schmaljohn C., Ibrahim M.S. Identification of Dobrava, Hantaan, Seoul, and Puumala viruses by one-step real-time RT-PCR. J. Virol. Methods 2005, 124:21-26.
2. Antoniades A., Grekas D., Rossi C.A., LeDuc J.W. Isolation of a hantavirus from a severely ill patient with hemorrhagic fever with renal syndrome in Greece. J. Infect. Dis. 1987, 156:1010-1013.
3. Antoniadis A., Pyrpasopoulos M., Sion M., Daniel S., Peters C.J. Two cases of hemorrhagic fever with renal syndrome in northern Greece. J. Infect. Dis. 1984, 149:1011-1013.
4. Antoniadis A., Le Duc J.W., Daniel-Alexiou S. Clinical and epidemiological aspects of hemorrhagic fever with renal syndrome (HFRS) in Greece. Eur. J. Epidemiol. 1987, 3:295-301.
5. Antoniadis A., Stylianakis A., Papa A., Alexiou-Daniel S., Lampropoulos A., Nichol S.T., Peters C.J., Spiropoulou C.F. Direct genetic detection of Dobrava virus in Greek and Albanian patients with hemorrhagic fever with renal syndrome. J. Infect. Dis. 1996, 174:407-410.
6. Araki K., Yoshimatsu K., Ogino M., Ebihara H., Lundkvist A., Kariwa H., Takashima I., Arikawa J. Truncated hantavirus nucleocapsid proteins for serotyping Hantaan, Seoul, and Dobrava hantavirus infections. J. Clin. Microbiol. 2001, 39:2397-2404.
7. Araki K., Yoshimatsu K., Lee B.H., Kariwa H., Takashima I., Arikawa J. A new model of Hantaan virus persistence in mice. the balance between HTNV infection and CD8(+) T-cell responses. Virology 2004, 322:318-327.
8. Avsic-Zupanc T., Cizman B., Gligic A., Hoofd G., van der Groen G. Evidence for Hantavirus disease in Slovenia, Yugoslavia. Acta Virol. 1989, 33:327-337.
9. Avsic-Zupanc T., Xiao S.Y., Stojanovic R., Gligic A., van der Groen G., LeDuc J.W. Characterization of Dobrava virus: a Hantavirus from Slovenia, Yugoslavia. J. Med. Virol. 1992, 38:132-137.
10. Avsic-Zupanc T., Poljak M., Furlan P., Kaps R., Xiao S.Y., Leduc J.W. Isolation of a strain of a Hantaan virus from a fatal case of hemorrhagic fever with renal syndrome in Slovenia. Am. J. Trop. Med. Hyg. 1994, 51:393-400.
11. Avsic-Zupanc T., Toney A., Anderson K., Chu Y.K., Schmaljohn C. Genetic and antigenic properties of Dobrava virus: a unique member of the Hantavirus genus, family Bunyaviridae. J. Gen. Virol. 1995, 76(Pt 11):2801-2808.
12. Avsic-Zupanc T., Petrovec M., Furlan P., Kaps R., Elgh F., Lundkvist A. Hemorrhagic fever with renal syndrome in the Dolenjska region of Slovenia -a 10-year survey. Clin. Infect. Dis. 1999, 28:860-865.
13. Avsic-Zupanc T., Nemirov K., Petrovec M., Trilar T., Poljak M., Vaheri A., Plyusnin A. Genetic analysis of wild-type Dobrava hantavirus in Slovenia: co-existence of two distinct genetic lineages within the same natural focus. J. Gen. Virol. 2000, 81:1747-1755.
14. Badger C.V., Richardson J.D., Dasilva R.L., Richards M.J., Josleyn M.D., Dupuy L.C., Hooper J.W., Schmaljohn C.S. Development and application of a flow cytometric potency assay for DNA vaccines 2011, Vaccine.
15. Battisti A.J., Chu Y.K., Chipman P.R., Kaufmann B., Jonsson C.B., Rossmann M.G. Structural studies of Hantaan virus. J. Virol. 2011, 85:835-841.
16. Bogdanovic R., Gligic A., Nikolic V., Ognjanovic M. Belgrade and Hantaan hantaviruses-the causative agents of haemorrhagic fever with renal syndrome in children in Serbia. Srp. Arh. Celok. Lek. 1995, 123:12-17.
17. Buranda T., Wu Y., Perez D., Jett S.D., BonduHawkins V., Ye C., Edwards B., Hall P., Larson R.S., Lopez G.P., Sklar L.A., Hjelle B. Recognition of decay accelerating factor and alpha(v)beta(3) by inactivated hantaviruses: toward the development of high-throughput screening flow cytometry assays. Anal. Biochem. 2010, 402:151-160.
18. Cebalo L., Dusek T., Kuzman I., Markotic A. Grading the severity of disease in patients with Puumala or Dobrava virus infections from 1995 to 2000 in Croatia. Acta Med. Croatica 2003, 57:355-359.
19. Chumakov M., Shindarov L., Gavrilovskaya I., Vasilenko S., Gorbachkova E., Katzarov G. Seroepidemiology of haemorrhagic fever with renal syndrome in Bulgaria. Acta Virol. 1988, 32:261-266.
20. Chung D.H., Kumarapperuma S.C., Sun Y., Li Q., Chu Y.K., Arterburn J.B., Parker W.B., Smith J., Spik K., Ramanathan H.N., Schmaljohn C.S., Jonsson C.B. Synthesis of 1-beta-d-ribofuranosyl-3-ethynyl-[1,2,4]triazole and its in vitro and in vivo efficacy against Hantavirus. Antiviral Res. 2008, 79:19-27.
21. Clement J., Maes P., Lagrou K., Van Ranst M., Lameire N. A unifying hypothesis and a single name for a complex globally emerging infection: hantavirus disease. Eur. J. Clin. Microbiol. Infect. Dis. 2012, 31:1-5.
22. Dzagurova T.K., Klempa B., Tkachenko E.A., Slyusareva G.P., Morozov V.G., Auste B., Kruger D.H. Molecular diagnostics of hemorrhagic fever with renal syndrome during a Dobrava virus infection outbreak in the European part of Russia. J. Clin. Microbiol. 2009, 47:4029-4036.
23. Dzagurova T.K., Witkowski P.T., Tkachenko E.A., Klempa B., Morozov V.G., Auste B., Zavora D.L., Iunicheva I.V., Mutnih E.S., Kruger D.H. Isolation of Sochi virus from a fatal case of hantavirus disease with fulminant clinical course. Clin. Infect. Dis. 2012, 54:e1-e4.
24. Easterbrook J.D., Klein S.L. Immunological mechanisms mediating hantavirus persistence in rodent reservoirs. PLoS Pathog. 2008, 4:e1000172.
25. Eboriadou M., Kalevrosoglou I., Varlamis G., Mitsiakos G., Papa A., Antoniadis A. Hantavirus nephropathy in a child. Nephrol. Dial. Transplant. 1999, 14:1040-1041.
26. Elgh F., Lundkvist A., Alexeyev O.A., Stenlund H., Avsic-Zupanc T., Hjelle B., Lee H.W., Smith K.J., Vainionpaa R., Wiger D., Wadell G., Juto P. Serological diagnosis of hantavirus infections by an enzyme-linked immunosorbent assay based on detection of immunoglobulin G and M responses to recombinant nucleocapsid proteins of five viral serotypes. J. Clin. Microbiol. 1997, 35:1122-1130.
27. Elisaf M., Antoniadis A., Siamopoulos K. Mild human infections of HFRS in northwestern Greece. J. Virol. Dis. 1993, 1:28-30.
28. Elisaf M., Korakis H., Siamopoulos K.C. Chronic renal dysfunction in hemorrhagic fever with renal syndrome patients. Ren. Fail. 1993, 15:623-627.
29. Elisaf M., Stefanaki S., Repanti M., Korakis H., Tsianos E., Siamopoulos K.C. Liver involvement in hemorrhagic fever with renal syndrome. J. Clin. Gastroenterol. 1993, 17:33-37.
30. Eltari E., Nuti M., Hasko I., Gina A. Haemorrhagic fever with renal syndrome in a case in northern Albania. Lancet 1987, 2:1211.
31. Ertek, M. and Buzgan, T., 2009. An outbreak caused by hantavirus in the Black Sea region of Turkey, January-May 2009. Euro Surveill 14.
32. Fauquet C.M., Mayo M.A., Maniloff J., Desselberger U., Ball L.A. Virus Taxonomy 2005, Eighth Report of the International Committee on Taxonomy of Viruses Amsterdam.
33. Garanina S.B., Platonov A.E., Zhuravlev V.I., Murashkina A.N., Yakimenko V.V., Korneev A.G., Shipulin G.A. Genetic diversity and geographic distribution of hantaviruses in Russia. Zoonoses Public Health 2009, 56:297-309.
34. Gavrilovskaya I.N., Vasilenko L.E., Chumakov M.P., Sindarov L., Kacarov G. Hemorrhagic fever with renal sydrome in Bulgaria: spreading and serologic proof. Epidemiol. Microbiol. Infekt Bol. 1984, 21:17-22.
35. Gavrilovskaya I.N., Gorbunova E.E., Mackow N.A., Mackow E.R. Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphingosine 1-phosphate inhibit hantavirus-directed permeability. J. Virol. 2008, 82:5797-5806.
36. Geldmacher A., Schmaler M., Kruger D.H., Ulrich R. Yeast-expressed hantavirus Dobrava nucleocapsid protein induces a strong, long-lasting, and highly cross-reactive immune response in mice. Viral Immunol. 2004, 17:115-122.
37. Geldmacher A., Skrastina D., Borisova G., Petrovskis I., Kruger D.H., Pumpens P., Ulrich R. A hantavirus nucleocapsid protein segment exposed on hepatitis B virus core particles is highly immunogenic in mice when applied without adjuvants or in the presence of pre-existing anti-core antibodies. Vaccine 2005, 23:3973-3983.
38. Gledovic Z.B., Jeknic A.S., Grgurevic A.D., Rakocevic B.B., Bozovic B.R., Mugosa B.V. Hemorrhagic fever with renal syndrome in Montenegro. Jpn. J. Infect. Dis. 2008, 61:386-387.
39. Gligic A., Obradovic M., Stojanovic R., Hlaca D., Antonijevic B., Arnautovic A., Gaon J., Frusic M., Lee P., Goldgaber D., et al. Hemorrhagic fever with renal syndrome in Yugoslavia: detection of hantaviral antigen and antibody in wild rodents and serological diagnosis of human disease. Scand. J. Infect. Dis. 1988, 20:261-266.
40. Gligic A., Frusic M., Obradovic M., Stojanovic R., Hlaca D., Gibbs C.J., Yanagihara R., Calisher C.H., Gajdusek D.C. Hemorrhagic fever with renal syndrome in Yugoslavia: antigenic characterization of hantaviruses isolated from Apodemus flavicollis and Clethrionomys glareolus. Am. J. Trop. Med. Hyg. 1989, 41:109-115.
41. Gligic A., Obradovic M., Stojanovic R., Vujosevic N., Ovcaric A., Frusic M., Gibbs C.J., Calisher C.H., Gajdusek D.C. Epidemic hemorrhagic fever with renal syndrome in Yugoslavia, 1986. Am. J. Trop. Med. Hyg. 1989, 41:102-108.
42. Gligic A., Dimkovic N., Xiao S.Y., Buckle G.J., Jovanovic D., Velimirovic D., Stojanovic R., Obradovic M., Diglisic G., Micic J., et al. Belgrade virus: a new hantavirus causing severe hemorrhagic fever with renal syndrome in Yugoslavia. J. Infect. Dis. 1992, 166:113-120.
43. Gligic A., Stojanovic R., Obradovic M., Hlaca D., Dimkovic N., Diglisic G., Lukac V., Ler Z., Bogdanovic R., Antonijevic B., et al. Hemorrhagic fever with renal syndrome in Yugoslavia: epidemiologic and epizootiologic features of a nationwide outbreak in 1989. Eur. J. Epidemiol. 1992, 8:816-825.
44. Gligic A., Bozovic B., Ristanovic E., Skataric V., Vesna B., Golubovic S. Characteristics of hemorrhagic fever with renal sydrome in former Yugoslavia in war condition. Med. Data Rev. 2010, 2:175-180.
45. Golovljova I., Vasilenko V., Prukk T., Brus Sjolander K., Plyusnin A., Lundkvist A. Puumala and Dobrava hantaviruses causing hemorrhagic fever with renal syndrome in Estonia. Eur. J. Clin. Microbiol. Infect. Dis. 2000, 19:968-969.
46. Golovljova I., Vasilenko V., Mittzenkov V., Prukk T., Seppet E., Vene S., Settergren B., Plyusnin A., Lundkvist A. Characterization of hemorrhagic fever with renal syndrome caused by hantaviruses, Estonia. Emerg. Infect. Dis. 2007, 13:1773-1776.
47. Gorbunova E.E., Gavrilovskaya I.N., Pepini T., Mackow E.R. VEGFR2 and Src kinase inhibitors suppress Andes virus-induced endothelial cell permeability. J. Virol. 2011, 85:2296-2303.
48. Hall P.R., Leitao A., Ye C., Kilpatrick K., Hjelle B., Oprea T.I., Larson R.S. Small molecule inhibitors of hantavirus infection. Bioorg. Med. Chem. Lett. 2010, 20:7085-7091.
49. Hammerbeck C.D., Hooper J.W. T cells are not required for pathogenesis in the Syrian hamster model of hantavirus pulmonary syndrome 2011, J. Virol.
50. Heyman P., Vaheri A., Lundkvist A., Avsic-Zupanc T. Hantavirus infections in Europe: from virus carriers to a major public-health problem. Expert Rev. Anti Infect. Ther. 2009, 7:205-217.
51. Heyman, P., Ceianu, C., Christova, I., Tordo, N., Beersma, M., Joao Alves, M., Lundkvist, A., Hukic, M., Papa, A., Tenorio, A., Zelena, H., Ebbauer, S., Visontai, I., Golovljova, I., Connell, J., Nicoletti, L., Van Esbroeck, M., Gjeruldsen Dudman, S., Aberle, S., Avsic-Zupanc, T., Korukluoglu, G., Nowakowska, A., Klempa, B., Ulrich, R., Bino, S., Engler, O., Opp, M. and Vaheri, A., 2011a. A five-year perspective on the situation of haemorrhagic fever with renal syndrome and status of the hantavirus reservoirs in Europe, 2005-2010. Euro Surveill 16.
52. Heyman P., Cochez C., Korukluoglu G., Gozalan A., Uyar Y., Lundkvist A. Bridging continents; Hantaviruses of Europe and Asia Minor. Turk. Hij. Den. Biyol. Derg. 2011, 68:41-48.
53. Hooper J.W., Custer D.M., Thompson E., Schmaljohn C.S. DNA vaccination with the Hantaan virus M gene protects hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys. J. Virol. 2001, 75:8469-8477.
54. Hooper J.W., Larsen T., Custer D.M., Schmaljohn C.S. A lethal disease model for hantavirus pulmonary syndrome. Virology 2001, 289:6-14.
55. Huggins J.W., Hsiang C.M., Cosgriff T.M., Guang M.Y., Smith J.I., Wu Z.O., LeDuc J.W., Zheng Z.M., Meegan J.M., Wang Q.N., et al. Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J. Infect. Dis. 1991, 164:1119-1127.
56. Huiskonen J.T., Hepojoki J., Laurinmaki P., Vaheri A., Lankinen H., Butcher S.J., Grunewald K. Electron cryotomography of Tula hantavirus suggests a unique assembly paradigm for enveloped viruses. J. Virol. 2010, 84:4889-4897.
57. Hujakka H., Koistinen V., Kuronen I., Eerikainen P., Parviainen M., Lundkvist A., Vaheri A., Vapalahti O., Narvanen A. Diagnostic rapid tests for acute hantavirus infections: specific tests for Hantaan, Dobrava and Puumala viruses versus a hantavirus combination test. J. Virol. Methods 2003, 108:117-122.
58. Hukic M., Kurt A., Torstensson S., Lundkvist A., Wiger D., Niklasson B. Haemorrhagic fever with renal syndrome in north-east Bosnia. Lancet 1996, 347:56-57.
59. Hukic M., Nikolic J., Valjevac A., Seremet M., Tesic G., Markotic A. A serosurvey reveals Bosnia and Herzegovina as a Europe's hotspot in hantavirus seroprevalence. Epidemiol. Infect. 2009, 138:1185-1193.
60. Jakab F., Sebok J., Ferenczi E., Horvath G., Szucs G. First detection of Dobrava hantavirus from a patient with severe haemorrhagic fever with renal syndrome by SYBR green-based real time RT-PCR. Scand. J. Infect. Dis. 2007, 39:902-906.
61. Jonsson C.B., Figueiredo L.T., Vapalahti O. A global perspective on hantavirus ecology, epidemiology, and disease. Clin. Microbiol. Rev. 2010, 23:412-441.
62. Kallio-Kokko H., Lundkvist A., Plyusnin A., Avsic-Zupanc T., Vaheri A., Vapalahti O. Antigenic properties and diagnostic potential of recombinant dobrava virus nucleocapsid protein. J. Med. Virol. 2000, 61:266-274.
63. Kanerva M., Mustonen J., Vaheri A. Pathogenesis of puumala and other hantavirus infections. Rev. Med. Virol. 1998, 8:67-86.
64. Kaya S., Yilmaz G., Erensoy S., Yagci Caglayik D., Uyar Y., Koksal I. Hantavirus infection: two case reports from a province in the Eastern Blacksea Region, Turkey. Mikrobiyol. Bull. 2010, 44:479-487.
65. Kirsanovs S., Klempa B., Franke R., Lee M.H., Schonrich G., Rang A., Kruger D.H. Genetic reassortment between high-virulent and low-virulent Dobrava-Belgrade virus strains. Virus Genes 2010, 41:319-328.
66. Klempa B., Schmidt H.A., Ulrich R., Kaluz S., Labuda M., Meisel H., Hjelle B., Kruger D.H. Authors' reply to: Genetic interaction between Dobrava and Saaremaa hantaviruses: now or millions of years ago?. J. Virol. 2003, 77:7157-7158.
67. Klempa B., Schmidt H.A., Ulrich R., Kaluz S., Labuda M., Meisel H., Hjelle B., Kruger D.H. Genetic interaction between distinct Dobrava hantavirus subtypes in Apodemus agrarius and A. flavicollis in nature. J. Virol. 2003, 77:804-809.
68. Klempa B., Schutt M., Auste B., Labuda M., Ulrich R., Meisel H., Kruger D.H. First molecular identification of human Dobrava virus infection in central Europe. J. Clin. Microbiol. 2004, 42:1322-1325.
69. Klempa B., Stanko M., Labuda M., Ulrich R., Meisel H., Kruger D.H. Central European Dobrava Hantavirus isolate from a striped field mouse (Apodemus agrarius). J. Clin. Microbiol. 2005, 43:2756-2763.
70. Klempa B., Fichet-Calvet E., Lecompte E., Auste B., Aniskin V., Meisel H., Denys C., Koivogui L., Ter Meulen J., Kruger D.H. Hantavirus in African wood mouse, Guinea. Emerg. Infect. Dis. 2006, 12:838-840.
71. Klempa B., Tkachenko E.A., Dzagurova T.K., Yunicheva Y.V., Morozov V.G., Okulova N.M., Slyusareva G.P., Smirnov A., Kruger D.H. Hemorrhagic fever with renal syndrome caused by 2 lineages of Dobrava hantavirus, Russia. Emerg. Infect. Dis. 2008, 14:617-625.
72. Klingstrom J., Maljkovic I., Zuber B., Rollman E., Kjerrstrom A., Lundkvist A. Vaccination of C57/BL6 mice with Dobrava hantavirus nucleocapsid protein in Freund's adjuvant induced partial protection against challenge. Vaccine 2004, 22:4029-4034.
73. Klingstrom J., Falk K.I., Lundkvist A. Delayed viremia and antibody responses in Puumala hantavirus challenged passively immunized cynomolgus macaques. Arch. Virol. 2005, 150:79-92.
74. Klingstrom J., Hardestam J., Lundkvist A. Dobrava, but not Saaremaa, hantavirus is lethal and induces nitric oxide production in suckling mice. Microbes Infect. 2006, 8:728-737.
75. Korva M., Duh D., Saksida A., Trilar T., Avsic-Zupanc T. The hantaviral load in tissues of naturally infected rodents. Microbes Infect. 2009, 11:344-351.
76. Korva M., Saksida A., Kunilo S., Vidan Jeras B., Avsic-Zupanc T. HLA associated hemorrhagic fever with renal syndrome disease progression in Slovenian patients. Clin. Vacc. Immunol. 2011, 18:1435-1440.
77. Koster F., Mackow E.R. Pathogenesis of the hantavirus pulmonary syndrome. Future Virol. 2012, 7:41-51.
78. Kramski M., Meisel H., Klempa B., Kruger D.H., Pauli G., Nitsche A. Detection and typing of human pathogenic hantaviruses by real-time reverse transcription-PCR and pyrosequencing. Clin. Chem. 2007, 53:1899-1905.
79. Krautkramer E., Zeier M. Hantavirus causing hemorrhagic fever with renal syndrome enters from the apical surface and requires decay-accelerating factor (DAF/CD55). J. Virol. 2008, 82:4257-4264.
80. Kruger D.H., Ulrich R., Lundkvist A.A. Hantavirus infections and their prevention. Microbes Infect. 2001, 3:1129-1144.
81. Kruger D.H., Schonrich G., Klempa B. Human pathogenic hantaviruses and prevention of infection. Hum Vaccin 2011, 7:685-693.
82. Kuzman I., Markotic A., Turcinov D., Beus I. An epidemic of hemorrhagic fever with renal syndrome in Croatia in 1995. Lijec. Vjesn. 1997, 119:311-315.
83. Kuzman I., Puljiz I., Turcinov D., Markotic A., Turkovic B., Aleraj B., Andric Z., Petkovic D., Tutek V., Herendic B., Iskra M., Pandak N., Misetic Z., Peric L., Jelaska D., Majetic-Sekovanic M., Ledina D., Misic-Majerus L., Radonic R. The biggest epidemic of hemorrhagic fever with renal syndrome in Croatia. Acta Med. Croatica 2003, 57:337-346.
84. LeDuc J.W., Antoniades A., Siamopoulos K. Epidemiological investigations following an outbreak of hemorrhagic fever with renal syndrome in Greece. Am. J. Trop. Med. Hyg. 1986, 35:654-659.
85. Lee H.W., Antoniadis A. Serological evidence for Korean haemorrhagic Fever in Greece. Lancet 1981, 8224:832.
86. Lee H.W., Lee P.W., Johnson K.M. Isolation of the etiologic agent of Korean Hemorrhagic fever. J. Infect. Dis. 1978, 137:298-308.
87. Lee P.W., Amyx H.L., Gibbs C.J., Gajdusek D.C., Lee H.W. Propagation of Korean hemorrhagic fever virus in laboratory rats. Infect. Immun. 1981, 31:334-338.
88. Lundkvist A., Apekina N., Myasnikov Y., Vapalahti O., Vaheri A., Plyusnin A. Dobrava hantavirus outbreak in Russia. Lancet 1997, 350:781-782.
89. Lundkvist A., Hukic M., Horling J., Gilljam M., Nichol S., Niklasson B. Puumala and Dobrava viruses cause hemorrhagic fever with renal syndrome in Bosnia-Herzegovina: evidence of highly cross-neutralizing antibody responses in early patient sera. J. Med. Virol. 1997, 53:51-59.
90. Lundkvist A., Vasilenko V., Golovljova I., Plyusnin A., Vaheri A. Human Dobrava hantavirus infections in Estonia. Lancet 1998, 352:369.
91. Lundkvist A., Lindegren G., Brus Sjolander K., Mavtchoutko V., Vene S., Plyusnin A., Kalnina V. Hantavirus infections in Latvia. Eur. J. Clin. Microbiol. Infect. Dis. 2002, 21:626-629.
92. Mackow E.R., Gavrilovskaya I.N. Hantavirus regulation of endothelial cell functions. Thromb. Haemost. 2009, 102:1030-1041.
93. Maes P., Clement J., Gavrilovskaya I., Van Ranst M. Hantaviruses: immunology, treatment, and prevention. Viral Immunol. 2004, 17:481-497.
94. Maes P., Klempa B., Clement J., Matthijnssens J., Gajdusek D.C., Kruger D.H., Van Ranst M. A proposal for new criteria for the classification of hantaviruses, based on S and M segment protein sequences. Infect. Genet. Evol. 2009, 9:813-820.
95. Markotic A., Dasic G., Gagro A., Sabioncello A., Rabatic S., Kuzman I., Zgorelec R., Smoljan I., Beus I., Zupanc T.A., Dekaris D. Role of peripheral blood mononuclear cell (PBMC) phenotype changes in the pathogenesis of haemorrhagic fever with renal syndrome (HFRS). Clin. Exp. Immunol. 1999, 115:329-334.
96. Markotic A., Kuzman I., Babic K., Gagro A., Nichol S., Ksiazek T.G., Rabatic S., Dekaris D. Double trouble: hemorrhagic fever with renal syndrome and leptospirosis. Scand. J. Infect. Dis. 2002, 34:221-224.
97. Markotic A., Nichol S.T., Kuzman I., Sanchez A.J., Ksiazek T.G., Gagro A., Rabatic S., Zgorelec R., Avsic-Zupanc T., Beus I., Dekaris D. Characteristics of Puumala and Dobrava infections in Croatia. J. Med. Virol. 2002, 66:542-551.
98. Martinez V.P., Padula P.J. Induction of protective immunity in a Syrian hamster model against a cytopathogenic strain of Andes virus. J. Med. Virol. 2012, 84:87-95.
99. Meisel H., Lundkvist A., Gantzer K., Bar W., Sibold C., Kruger D.H. First case of infection with hantavirus Dobrava in Germany. Eur. J. Clin. Microbiol. Infect. Dis. 1998, 17:884-885.
100. Meisel H., Wolbert A., Razanskiene A., Marg A., Kazaks A., Sasnauskas K., Pauli G., Ulrich R., Kruger D.H. Development of novel immunoglobulin G (IgG), IgA, and IgM enzyme immunoassays based on recombinant Puumala and Dobrava hantavirus nucleocapsid proteins. Clin. Vaccine Immunol. 2006, 13:1349-1357.
101. Mentel R., Bordihn N., Wegner U., Wendel H., Niklasson B. Hantavirus Dobrava infection with pulmonary manifestation. Med. Microbiol. Immunol. 1999, 188:51-53.
102. Michaux J.R., Pasquier L. Dynamique des populations de mulots (Rodentia, Apodemus) en Europe durant le Quaternaire. Premières données. Bull. Soc. Géol. France 1974, 7:431-439.
103. Mustonen J., Partanen J., Kanerva M., Pietila K., Vapalahti O., Pasternack A., Vaheri A. Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus. Kidney Int. 1996, 49:217-221.
104. Nemeth V., Madai M., Maraczi A., Berczi B., Horvath G., Oldal M., Kisfali P., Banyai K., Jakab F. Detection of Dobrava-Belgrade hantavirus using recombinant-nucleocapsid-based enzyme-linked immunosorbent assay and SYBR Green-based real-time reverse transcriptase-polymerase chain reaction 2011, Arch Virol.
105. Nemirov K., Vapalahti O., Lundkvist A., Vasilenko V., Golovljova I., Plyusnina A., Niemimaa J., Laakkonen J., Henttonen H., Vaheri A., Plyusnin A. Isolation and characterization of Dobrava hantavirus carried by the striped field mouse (Apodemus agrarius) in Estonia. J. Gen. Virol. 1999, 80:371-379.
106. Nemirov K., Henttonen H., Vaheri A., Plyusnin A. Phylogenetic evidence for host switching in the evolution of hantaviruses carried by Apodemus mice. Virus Res. 2002, 90:207-215.
107. Nemirov K., Vapalahti O., Papa A., Plyusnina A., Lundkvist A., Antoniadis A., Vaheri A., Plyusnin A. Genetic characterization of new Dobrava hantavirus isolate from Greece. J. Med. Virol. 2003, 69:408-416.
108. Nemirov K., Andersen H.K., Leirs H., Henttonen H., Vaheri A., Lundkvist A., Plyusnin A. Saaremaa hantavirus in Denmark. J. Clin. Virol. 2004, 30:254-257.
109. Nowakowska A., Heyman P., Knap J.P., Burzynski W., Witas M. The first established focus of hantavirus infection in Poland, 2007. Ann. Agric. Environ. Med. 2009, 16:79-85.
110. Oncul O., Atalay Y., Onem Y., Turhan V., Acar A., Uyar Y., Caglayik D.Y., Ozkan S., Gorenek L. Hantavirus infection in Istanbul, Turkey. Emerg. Infect. Dis. 2011, 17:303-304.
111. Papa A., Antoniadis A. Hantavirus infections in Greece-an update. Eur. J. Epidemiol. 2001, 17:189-194.
112. Papa A., Christova I. Genetic detection of Dobrava/Belgrade virus, Bulgaria. Emerg. Infect. Dis. 2011, 17:308-309.
113. Papa A., Johnson A.M., Stockton P.C., Bowen M.D., Spiropoulou C.F., Alexiou-Daniel S., Ksiazek T.G., Nichol S.T., Antoniadis A. Retrospective serological and genetic study of the distribution of hantaviruses in Greece. J. Med. Virol. 1998, 55:321-327.
114. Papa A., Mills J.N., Kouidou S., Ma B., Papadimitriou E., Antoniadis A. Preliminary characterization and natural history of hantaviruses in rodents in northern Greece. Emerg. Infect. Dis. 2000, 6:654-655.
115. Papa A., Spiropoulou C., Nichol S., Antoniadis A. Tracing Dobrava hantavirus infection. J. Infect. Dis. 2000, 181:2116-2117.
116. Papa A., Nemirov K., Henttonen H., Niemimaa J., Antoniadis A., Vaheri A., Plyusnin A., Vapalahti O. Isolation of Dobrava virus from Apodemus flavicollis in Greece. J. Clin. Microbiol. 2001, 39:2291-2293.
117. Papa A., Bojovic B., Antoniadis A. Hantaviruses in Serbia and Montenegro. Emerg. Infect. Dis. 2006, 12:1015-1018.
118. Papa A., Rogozi E., Velo E., Papadimitriou E., Bino S., Antoniadis A. Genetic Detection of Hantaviruses in Albanian Rodents. VII International Conference on HFRS 2006, HPS and hantaviruses, Abstract book, p. 128.
119. Papa A., Bino S., Papadimitriou E., Velo E., Dhimolea M., Antoniadis A. Suspected Crimean Congo Haemorrhagic Fever cases in Albania. Scand. J. Infect. Dis. 2008, 40:978-980.
120. Papa A., Zelena H., Barnetova D., Petrousova L. Genetic detection of Dobrava/Belgrade virus in a Czech patient with Haemorrhagic fever with renal syndrome. Clin. Microbiol. Infect. 2010, 16:1187-1190.
121. Papadimitriou M. Hantavirus nephropathy. Kidney Int. 1995, 48:887-902.
122. Papadimitriou M.G., Antoniadis A. Hantavirus nephropathy in Greece. Lancet 1994, 343:1038.
123. Peco-Antic A., Popovic-Rolovic M., Gligic A., Popovic D., Jovanovic O., Kostic M. Clinical characteristics of haemorrhagic fever with renal syndrome in children. Pediatr. Nephrol. 1992, 6:335-338.
124. Plyusnin A., Vapalahti O., Vasilenko V., Henttonen H., Vaheri A. Dobrava hantavirus in Estonia: does the virus exist throughout Europe?. Lancet 1997, 349:1369-1370.
125. Plyusnin A., Nemirov K., Apekina N., Plyusnina A., Lundkvist A., Vaheri A. Dobrava hantavirus in Russia. Lancet 1999, 353:207.
126. Plyusnin A., Vaheri A., Lundkvist A. Genetic interaction between Dobrava and Saaremaa hantaviruses: now or millions of years ago?. J. Virol. 2003, 77:7157-7158.
127. Plyusnina A., Ferenczi E., Racz G.R., Nemirov K., Lundkvist A., Vaheri A., Vapalahti O., Plyusnin A. Co-circulation of three pathogenic hantaviruses: Puumala, Dobrava, and Saaremaa in Hungary. J. Med. Virol. 2009, 81:2045-2052.
128. Plyusnina A., Krajinovic L.C., Margaletic J., Niemimaa J., Nemirov K., Lundkvist A., Markotic A., Miletic-Medved M., Avsic-Zupanc T., Henttonen H., Plyusnin A. Genetic evidence for the presence of two distinct hantaviruses associated with Apodemus mice in Croatia and analysis of local strains. J. Med. Virol. 2011, 83:108-114.
129. Popugaeva E., Witkowski P.T., Schlegel M., Ulrich R.G., Auste B.A.R., Krüger D., Klempa B. Dobrava-Belgrade hantavirus from Germany shows receptor usage and innate immunity induction consistent with the pathogenicity of the virus in humans. PLoS ONE 2012, 7:e35587.
130. Ramsden C., Holmes E.C., Charleston M.A. Hantavirus evolution in relation to its rodent and insectivore hosts: no evidence for codivergence. Mol. Biol. Evol. 2009, 26:143-153.
131. Rusnak J.M. Experience with ribavirin for treatment and postexposure prophylaxis of hemorrhagic fever viruses: Crimean-Congo hemorrhagic fever, Lassa fever, and hantaviruses. Applied Biosafety 2011, 16:67-87.
132. Rusnak J.M., Byrne W.R., Chung K.N., Gibbs P.H., Kim T.T., Boudreau E.F., Cosgriff T., Pittman P., Kim K.Y., Erlichman M.S., Rezvani D.F., Huggins J.W. Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea. Antiviral Res. 2009, 81:68-76.
133. Safronetz D., Zivcec M., Lacasse R., Feldmann F., Rosenke R., Long D., Haddock E., Brining D., Gardner D., Feldmann H., Ebihara H. Pathogenesis and host response in Syrian hamsters following intranasal infection with Andes virus. PLoS Pathog. 2011, 7:e1002426.
134. Saksida A., Duh D., Korva M., Avsic-Zupanc T. Dobrava virus RNA load in patients who have hemorrhagic fever with renal syndrome. J. Infect. Dis. 2008, 197:681-685.
135. Saksida A., Wraber B., Avsic-Zupanc T. Serum levels of inflammatory and regulatory cytokines in patients with hemorrhagic fever with renal syndrome. BMC Infect. Dis. 2011, 11:142.
136. Sandmann S., Meisel H., Razanskiene A., Wolbert A., Pohl B., Kruger D.H., Sasnauskas K., Ulrich R. Detection of human hantavirus infections in Lithuania. Infection 2005, 33:66-72.
137. Sargianou M., Watson D.C., Chra P., Papa A., Starakis I., Gogos C., Panos G. Hantavirus infections for the clinician: From case presentation to diagnosis and treatment 2012, Crit. Rev. Microbiol.
138. Scharninghausen J.J., Meyer H., Pfeffer M., Davis D.S., Honeycutt R.L. Genetic evidence of Dobrava virus in Apodemus agrarius in Hungary. Emerg. Infect. Dis. 1999, 5:468-470.
139. Schlegel M., Klempa B., Auste B., Bemmann M., Schmidt-Chanasit J., Buchner T., Groschup M.H., Meier M., Balkema-Buschmann A., Zoller H., Kruger D.H., Ulrich R.G. Dobrava-Belgrade virus spillover infections, Germany. Emerg. Infect. Dis. 2009, 15:2017-2020.
140. Schlegel M., Radosa L., Rosenfeld U.M., Schmidt S., Triebenbacher C., Lohr P.W., Fuchs D., Heroldova M., Janova E., Stanko M., Mosansky L., Fricova J., Pejcoch M., Suchomel J., Purchart L., Groschup M.H., Kruger D.H., Klempa B., Ulrich R.G. Broad geographical distribution and high genetic diversity of shrew-borne Seewis hantavirus in Central Europe 2012, Virus Genes.
141. Schmaljohn C. Vaccines for hantaviruses. Vaccine 2009, 27:D61-D64.
142. Schmaljohn, C.S., Nichol, S.T., 2007. Bunyaviridae. In: Knipe, D.M., Howley, P.M. (Eds.), Fields Virology, Philadelphia: Lippincott, Williams and Wilkins, fifth edition. vol, 2, pp. 1741-1789.
143. Schonrich G., Rang A., Lutteke N., Raftery M.J., Charbonnel N., Ulrich R.G. Hantavirus-induced immunity in rodent reservoirs and humans. Immunol. Rev. 2008, 225:163-189.
144. Schutt M., Gerke P., Meisel H., Ulrich R., Kruger D.H. Clinical characterization of Dobrava hantavirus infections in Germany. Clin. Nephrol. 2001, 55:371-374.
145. Schutt M., Meisel H., Kruger D.H., Ulrich R., Dalhoff K., Dodt C. Life-threatening Dobrava hantavirus infection with unusually extended pulmonary involvement. Clin. Nephrol. 2004, 62:54-57.
146. Seto T., Nagata N., Yoshikawa K., Ichii O., Sanada T., Saasa N., Ozaki Y., Kon Y., Yoshii K., Takashima I., Kariwa H. Infection of Hantaan virus strain AA57 leading to pulmonary disease in laboratory mice. Virus Res. 2012, 163:284-290.
147. Severson W.E., Schmaljohn C.S., Javadian A., Jonsson C.B. Ribavirin causes error catastrophe during Hantaan virus replication. J. Virol. 2003, 77:481-488.
148. Shrivastava-Ranjan P., Rollin P.E., Spiropoulou C.F. Andes virus disrupts the endothelial cell barrier by induction of vascular endothelial growth factor and downregulation of VE-cadherin. J. Virol. 2010, 84:11227-11234.
149. Siamopoulos K., Antoniadis A., Acritidis N., Constantopoulos S., Tsianos E., Papapanagiotou I., Moutsopoulos H.M. Outbreak of hemorrhagic fever with renal sydrome in Greece. Eur J Clin Microbiol 1985, 4:132-134.
150. Siamopoulos K.C., Elisaf M., Antoniadis A., Moutsopoulos H.M. Hemorrhagic fever with renal syndrome in an endemic area of Greece. Am. J. Nephrol. 1992, 12:170-173.
151. Sibold C., Meisel H., Lundkvist A., Schulz A., Cifire F., Ulrich R., Kozuch O., Labuda M., Kruger D.H. Short report: simultaneous occurrence of Dobrava, Puumala, and Tula Hantaviruses in Slovakia. Am. J. Trop. Med. Hyg. 1999, 61:409-411.
152. Sibold C., Ulrich R., Labuda M., Lundkvist A., Martens H., Schutt M., Gerke P., Leitmeyer K., Meisel H., Kruger D.H. Dobrava hantavirus causes hemorrhagic fever with renal syndrome in central Europe and is carried by two different Apodemus mice species. J. Med. Virol. 2001, 63:158-167.
153. Sironen T., Vaheri A., Plyusnin A. Phylogenetic evidence for the distinction of Saaremaa and Dobrava hantaviruses. Virol. J. 2005, 2:90.
154. Sironen T., Klingstrom J., Vaheri A., Andersson L.C., Lundkvist A., Plyusnin A. Pathology of Puumala hantavirus infection in macaques. PLoS ONE 2008, 3:e3035.
155. Sjolander K.B., Lundkvist A. Dobrava virus infection: serological diagnosis and cross-reactions to other hantaviruses. J. Virol. Methods 1999, 80:137-143.
156. Sjolander K.B., Golovljova I., Vasilenko V., Plyusnin A., Lundkvist A. Serological divergence of Dobrava and Saaremaa hantaviruses: evidence for two distinct serotypes. Epidemiol. Infect. 2002, 128:99-103.
157. Song J.W., Baek L.J., Schmaljohn C.S., Yanagihara R. Thottapalayam virus, a prototype shrewborne hantavirus. Emerg. Infect. Dis. 2007, 13:980-985.
158. Steinberg B.E., Goldenberg N.M., Lee W.L. Do viral infections mimic bacterial sepsis? The role of microvascular permeability: A review of mechanisms and methods. Antiviral Res. 2012, 93:2-15.
159. Stojanovic M., Pekic S., Cvijovic G., Miljic D., Doknic M., Nikolic-Djurovic M., Micic D., Hrvacevic R., Nesic V., Popovic V. High risk of hypopituitarism in patients who recovered from hemorrhagic fever with renal syndrome. J. Clin. Endocrinol. Metab. 2008, 93:2722-2728.
160. Stoltz M., Ahlm C., Lundkvist A., Klingstrom J. Lambda interferon (IFN-lambda) in serum is decreased in hantavirus-infected patients, and in vitro-established infection is insensitive to treatment with all IFNs and inhibits IFN-gamma-induced nitric oxide production. J. Virol. 2007, 81:8685-8691.
161. Sun Y., Chung D.H., Chu Y.K., Jonsson C.B., Parker W.B. Activity of ribavirin against Hantaan virus correlates with production of ribavirin-5'-triphosphate, not with inhibition of IMP dehydrogenase. Antimicrob. Agents Chemother. 2007, 51:84-88.
162. Taller A.M., Xiao S.Y., Godec M.S., Gligic A., Avsic-Zupanc T., Goldfarb L.G., Yanagihara R., Asher D.M. Belgrade virus, a cause of hemorrhagic fever with renal syndrome in the Balkans, is closely related to Dobrava virus of field mice. J. Infect. Dis. 1993, 168:750-753.
163. Taylor S.L., Krempel R.L., Schmaljohn C.S. Inhibition of TNF-alpha-induced activation of NF-kappaB by hantavirus nucleocapsid proteins. Ann. N. Y. Acad. Sci. 2009, 1171(Suppl 1):E86-E93.
164. Terajima M., Ennis F.A. T cells and pathogenesis of hantavirus cardiopulmonary syndrome and hemorrhagic Fever with renal syndrome. Viruses 2011, 3:1059-1073.
165. Tkachenko E.A., Okulova N.M., Iunicheva Iu V., Morzunov S.P., Khaibulina S.F., Riabova T.E., Vasilenko L.E., Bashkirtsev V.N., Dzagurova T.K., Gorbachkova E.A., Sedova N.S., Balakirev A.E., Dekonenko A.E., Drozdov S.G. The epizootological and virological characteristics of a natural hantavirus infection focus in the subtropic zone of the Krasnodarsk Territory. Vopr. Virusol. 2005, 50:14-19.
166. Tsergouli K., Papadimitriou E., Gavana E., Papa A. Cytokine levels in hemorrhagic fever with renal sydrome caused by Dobrava-Belgrade virus, In: VIII International Conference on HFRS 2010, HPS and Hantaviruses, Athens, Greece, pp. 206.
167. Vaheri A., Vapalahti O., Plyusnin A. How to diagnose hantavirus infections and detect them in rodents and insectivores. Rev. Med. Virol. 2008, 18:277-288.
168. Weidmann M., Schmidt P., Vackova M., Krivanec K., Munclinger P., Hufert F.T. Identification of genetic evidence for dobrava virus spillover in rodents by nested reverse transcription (RT)-PCR and TaqMan RT-PCR. J. Clin. Microbiol. 2005, 43:808-812.
169. Xiao S.Y., Diglisic G., Avsic-Zupanc T., LeDuc J.W. Dobrava virus as a new Hantavirus: evidenced by comparative sequence analysis. J. Med. Virol. 1993, 39:152-155.
170. Xu R., Yang X.Y., Yang D.F., Zou C.Y., Gong P.L., Zeng F.D. Phase I evaluation of the safety and pharmacokinetics of a single-dose intravenous injection of a murine monoclonal antibody against Hantaan virus in healthy volunteers. Antimicrob. Agents Chemother. 2009, 53:5055-5059.
171. Zelena H., Zvolankova V., Zuchnicka J., Liszkova K., Papa A. Hantavirus infection during a stay in a mountain hut in Northern Slovakia. J. Med. Virol. 2011, 83:496-500.